Literature DB >> 16492625

Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study.

S D'Alisa1, G Miscio, S Baudo, A Simone, L Tesio, A Mauro.   

Abstract

PURPOSE: Quality of life in multiple sclerosis has been often measured through the SF-36 questionnaire. In this study, validation of the SF-36 summary scores, its 'physical' component, and its 'mental' component was attempted by exploring the joint predictive power of disability (EDSS score), of anxiety and depression (HADS-A and -D scores, respectively), and of disease duration, progression type, age, gender and marital status.
METHOD: The sample consisted of 75 patients suffering from multiple sclerosis admitted to an inpatient rehabilitation unit. The interplay between potential predictors was assessed through a particular regression model (classification and regression tree, CART). Two main advantages of this technique are its robustness with respect to distributional assumptions (rarely met by scores coming in from questionnaires) and its sensitivity to high-order interactions, between independent variables, difficult to detect through conventional multiple regression.
RESULTS: Predictive variables for physical component of the SF-36 were EDSS and HADS-D (36.8% variance explanation). The only predictive variable for mental component of SF-36 was HADS-D (39.1% variance explanation).
CONCLUSION: Results confirm previous findings showing that in patients with multiple sclerosis quality of life is heavily determined by person's mood, whatever his/her neurological or functional severity. The usefulness and validity of the SF-36 as an index representative of quality of life is debatable, as long as depression explains much of its variance. Further refinement of quality of life definition and measurement is worth further psychometric and statistical research.

Entities:  

Mesh:

Year:  2006        PMID: 16492625     DOI: 10.1080/09638280500191753

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  44 in total

Review 1.  [Adherence to neurologic treatment. Lessons from multiple sclerosis].

Authors:  S Kern; H Reichmann; T Ziemssen
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

2.  Factors that differentiate level of ambulation in hospitalised older adults.

Authors:  Steve R Fisher; James E Graham; Cynthia J Brown; Rebecca V Galloway; Kenneth J Ottenbacher; Richard M Allman; Glenn V Ostir
Journal:  Age Ageing       Date:  2011-09-09       Impact factor: 10.668

3.  Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

Authors:  Susan K Conroy; Katherine B Brownlowe; Thomas W McAllister
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

4.  What explains functioning from the perspective of people with multiple sclerosis?

Authors:  Andrea Conrad; Michaela Coenen; Jürg Kesselring; Alarcos Cieza
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

Review 5.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

6.  A Framework of Care in Multiple Sclerosis, Part 2: Symptomatic Care and Beyond.

Authors:  Scott D Newsome; Philip J Aliotta; Jacquelyn Bainbridge; Susan E Bennett; Gary Cutter; Kaylan Fenton; Fred Lublin; Dorothy Northrop; David Rintell; Bryan D Walker; Megan Weigel; Kathleen Zackowski; David E Jones
Journal:  Int J MS Care       Date:  2017 Jan-Feb

7.  Role of positive lifestyle activities on mood, cognition, well-being, and disease characteristics in multiple sclerosis.

Authors:  Lauren B Strober; Alexandra Becker; John J Randolph
Journal:  Appl Neuropsychol Adult       Date:  2018 Jul-Aug       Impact factor: 2.248

Review 8.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

9.  The use of focus groups to characterize symptoms in persons with multiple sclerosis.

Authors:  Pamela K Newland; Florian P Thomas; Marguerite Riley; Louise H Flick; Arleen Fearing
Journal:  J Neurosci Nurs       Date:  2012-12       Impact factor: 1.230

10.  Modifiable risk factors predicting major depressive disorder at four year follow-up: a decision tree approach.

Authors:  Philip J Batterham; Helen Christensen; Andrew J Mackinnon
Journal:  BMC Psychiatry       Date:  2009-11-22       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.